Magnolol: A multifunctional compound isolated from the Chinese medicinal plant Magnolia officinalis

European Journal of Integrative Medicine

Volumn 3, Issue 4, 2011, Pages e317-e324

  Chen, Yung Hsiang ^a,b   Huang, Po Hsun ^c,d   Lin, Feng Yen ^e   Chen, Wen Chi ^b   Chen, Yuh Lien ^f   Yin, Wei Hsian ^d,g   Man, Kee Ming ^a,h,i   Liu, Po Len ^j  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^h NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

ⁱ ANHUI MEDICAL UNIVERSITY   (China)

^j KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

more..

Author keywords

Antioxidant; Chinese medicine; Inflammation; Integrative medicine; Magnolol

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; MAGNOLIA OFFICINALIS EXTRACT; MAGNOLOL; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LIVER FAILURE; ADIPOCYTE; ANAPHYLAXIS; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ASTHMA; ATHEROSCLEROSIS; BACTERIAL INFECTION; CELL ADHESION; CHEST TIGHTNESS; CHINESE MEDICINE; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; FIBROBLAST; FIBROSARCOMA; GENE MUTATION; HEART MUSCLE CELL; HERBAL MEDICINE; HUMAN; INFLAMMATION; LIPID PEROXIDATION; LIVER INJURY; LIVER METASTASIS; LIVER MITOCHONDRION; LUNG CANCER; MAGNOLIACEAE; MEDICINAL PLANT; MEDLINE; MELANOMA; MOTOR CORTEX; MYCOSIS; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAIN; PHOTOAGING; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SKIN EDEMA; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; THYROID CARCINOMA;

EID: 82455208877     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2011.09.002     Document Type: Review

References (84)

1. Shen J.L., Man K.M., Huang P.H., Chen W.C., Chen D.C., Cheng Y.W., et al. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules 2010, 15:6452-6465.
2. Watanabe H., Watanabe K., Hagino K. Chemostructural requirement for centrally acting muscle relaxant effect of magnolol and honokiol, neolignane derivatives. J Pharmacobiodyn 1983, 6:184-190.
3. Taira J., Ikemoto T., Mimura K., Hagi A., Murakami A., Makino K. Effective inhibition of hydroxyl radicals by hydroxylated biphenyl compounds. Free Radic Res Commun 1993, 19(Suppl. 1):S71-S77.
4. Fujita S., Taira J. Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic Biol Med 1994, 17:273-277.
5. Lo Y.C., Teng C.M., Chen C.F., Chen C.C., Hong C.Y. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol 1994, 47:549-553.
6. Lee Y.J., Lee Y.M., Lee C.K., Jung J.K., Han S.B., Hong J.T. Therapeutic applications of compounds in the Magnolia family. Pharmacol Therap 2011, 130:157-176.
7. Fried L.E., Arbiser J.L. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 2009, 11:1139-1148.
8. Chiu J.H., Wang J.C., Lui W.Y., Wu C.W., Hong C.Y. Effect of magnolol on in vitro mitochondrial lipid peroxidation and isolated cold-preserved warm-reperfused rat livers. J Surg Res 1999, 82:11-16.
9. Hong C.Y., Huang S.S., Tsai S.K. Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation. Clin Exp Pharmacol Physiol 1996, 23:660-664.
10. Chang C.P., Hsu Y.C., Lin M.T. Magnolol protects against cerebral ischaemic injury of rat heatstroke. Clin Exp Pharmacol Physiol 2003, 30:387-392.
11. Li H.B., Gao J.M., Ying X.X., Wang S.P., Li J.C. Protective effect of magnolol on TBHP-induced injury in H460 cells partially via a p53 dependent mechanism. Arch Pharm Res 2007, 30:850-857.
12. Loong C.C., Chiu J.H., Tiao R.C., Chiu Y.Y., Wu C.W., Lui W.Y. Pretreatment with magnolol attenuates ischemia-reperfusion injury in rat small intestine. Transplant Proc 2001, 33:3737-3738.
13. Loong C.C., Chiu J.H., Tiao R.C., Chiu Y.Y., Wu C.W., Lui W.Y. Protective effect of magnolol on the small intestinal ischemia-reperfusion injury. Transplant Proc 2002, 34:2679-2680.
14. Wang J.P., Hsu M.F., Raung S.L., Chen C.C., Kuo J.S., Teng C.M. Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch Pharmacol 1992, 346:707-712.
15. Hsu M.F., Lu M.C., Tsao L.T., Kuan Y.H., Chen C.C., Wang J.P. Mechanisms of the influence of magnolol on eicosanoid metabolism in neutrophils. Biochem Pharmacol 2004, 67:831-840.
16. Wang J.P., Ho T.F., Chang L.C., Chen C.C. Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice. J Pharm Pharmacol 1995, 47:857-860.
17. Yamazaki R., Sugatani J., Fujii I., Kuroyanagi M., Umehara K., Ueno A., et al. Development of a novel method for determination of acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase activity and its application to screening for acetyltransferase inhibitors. Inhibition by magnolol and honokiol from Magnoliae cortex. Biochem Pharmacol 1994, 47:995-1006.
18. Homma M., Minami M., Taniguchi C., Oka K., Morita S., Niitsuma T., et al. Inhibitory effects of lignans and flavonoids in saiboku-to, a herbal medicine for bronchial asthma, on the release of leukotrienes from human polymorphonuclear leukocytes. Planta Med 2000, 66:88-91.
19. Homma M., Oka K., Niitsuma T., Itoh H. A novel 11 beta-hydroxysteroid dehydrogenase inhibitor contained in saiboku-to, a herbal remedy for steroid-dependent bronchial asthma. J Pharm Pharmacol 1994, 46:305-309.
20. Homma M., Oka K., Yamada T., Niitsuma T., Ihto H., Takahashi N. A strategy for discovering biologically active compounds with high probability in traditional Chinese herb remedies: an application of saiboku-to in bronchial asthma. Anal Biochem 1992, 202:179-187.
21. Ikarashi Y., Yuzurihara M., Sakakibara I., Nakai Y., Hattori N., Maruyama Y. Effects of the extract of the bark of Magnolia obovata and its biphenolic constituents magnolol and honokiol on histamine release from peritoneal mast cells in rats. Planta Med 2001, 67:709-713.
22. Niitsuma T., Morita S., Hayashi T., Homma M., Oka K. Effects of absorbed components of saiboku-to on the release of leukotrienes from polymorphonuclear leukocytes of patients with bronchial asthma. Methods Find Exp Clin Pharmacol 2001, 23:99-104.
23. Taniguchi C., Homma M., Takano O., Hirano T., Oka K., Aoyagi Y., et al. Pharmacological effects of urinary products obtained after treatment with saiboku-to, a herbal medicine for bronchial asthma, on type IV allergic reaction. Planta Med 2000, 66:607-611.
24. Hamasaki Y., Kobayashi I., Zaitu M., Tsuji K., Kita M., Hayasaki R., et al. Magnolol inhibits leukotriene synthesis in rat basophilic leukemia-2H3 cells. Planta Med 1999, 65:222-226.
25. Han S.J., Bae E.A., Trinh H.T., Yang J.H., Youn U.J., Bae K.H., et al. Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors. Biol Pharm Bull 2007, 30:2201-2203.
26. Son H.J., Lee H.J., Yun-Choi H.S., Ryu J.H. Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages. Planta Med 2000, 66:469-471.
27. Tanaka K., Hasegawa J., Asamitsu K., Okamoto T. Magnolia ovovata extract and its active component magnolol prevent skin photoaging via inhibition of nuclear factor kappaB. Eur J Pharmacol 2007, 565:212-219.
28. Wang J.P., Raung S.L., Chen C.C., Kuo J.S., Teng C.M. The inhibitory effect of magnolol on cutaneous permeability in mice is probably mediated by a nonselective vascular hyporeactivity to mediators. Naunyn Schmiedebergs Arch Pharmacol 1993, 348:663-669.
29. Ko C.H., Chen H.H., Lin Y.R., Chan M.H. Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea. Planta Med 2003, 69:532-536.
30. Wu S.N., Chen C.C., Li H.F., Lo Y.K., Chen S.A., Chiang H.T. Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol. Thorax 2002, 57:67-74.
31. Konoshima T., Kozuka M., Tokuda H., Nishino H., Iwashima A., Haruna M., et al. Studies on inhibitors of skin tumor promotion, IX Neolignans from Magnolia officinalis. J Nat Prod 1991, 54:816-822.
32. Lin S.Y., Chang Y.T., Liu J.D., Yu C.H., Ho Y.S., Lee Y.H., et al. Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol Carcinog 2001, 32:73-83.
33. Yang S.E., Hsieh M.T., Tsai T.H., Hsu S.L. Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells. Br J Pharmacol 2003, 138:193-201.
34. Huang S.H., Chen Y., Tung P.Y., Wu J.C., Chen K.H., Wu J.M., et al. Mechanisms for the magnolol-induced cell death of CGTH W-2 thyroid carcinoma cells. J Cell Biochem 2007, 101:1011-1022.
35. Ikeda K., Nagase H. Magnolol has the ability to induce apoptosis in tumor cells. Biol Pharm Bull 2002, 25:1546-1549.
36. You Q., Li M., Jiao G. Magnolol induces apoptosis via activation of both mitochondrial and death receptor pathways in A375-S2 cells. Arch Pharm Res 2009, 32:1789-1794.
37. Ikai T., Akao Y., Nakagawa Y., Ohguchi K., Sakai Y., Nozawa Y. Magnolol-induced apoptosis is mediated via the intrinsic pathway with release of AIF from mitochondria in U937 cells. Biol Pharm Bull 2006, 29:2498-2501.
38. Zhong W.B., Wang C.Y., Ho K.J., Lu F.J., Chang T.C., Lee W.S. Magnolol induces apoptosis in human leukemia cells via cytochrome c release and caspase activation. Anticancer Drugs 2003, 14:211-217.
39. Lee D.H., Szczepanski M.J., Lee Y.J. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J Cell Biochem 2009, 106:1113-1122.
40. Syu W.J., Shen C.C., Lu J.J., Lee G.H., Sun C.M. Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis. Chem Biodivers 2004, 1:530-537.
41. Li H.B., Yi X., Gao J.M., Ying X.X., Guan H.Q., Li J.C. Magnolol-induced H460 cells death via autophagy but not apoptosis. Arch Pharm Res 2007, 30:1566-1574.
42. Ikeda K., Sakai Y., Nagase H. Inhibitory effect of magnolol on tumour metastasis in mice. Phytother Res 2003, 17:933-937.
43. Teng C.M., Chen C.C., Ko F.N., Lee L.G., Huang T.F., Chen Y.P., et al. Two antiplatelet agents from Magnolia officinalis. Thromb Res 1988, 50:757-765.
44. Teng C.M., Ko F.N., Wang J.P., Lin C.N., Wu T.S., Chen C.C., et al. Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs. J Pharm Pharmacol 1991, 43:667-669.
45. Chen Y.H., Lin S.J., Chen Y.L., Liu P.L., Chen J.W. Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets 2006, 6:279-304.
46. Chen J.H., Wu C.C., Hsiao G., Yen M.H. Magnolol induces apoptosis in vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 2003, 368:127-133.
47. Wu C.H., Chen C.W., Chen H.C., Chang W.C., Shu M.J., Hung J.S. Elucidating the inhibitory mechanisms of magnolol on rat smooth muscle cell proliferation. J Pharmacol Sci 2005, 99:392-399.
48. Chen Y.L., Lin K.F., Shiao M.S., Chen Y.T., Hong C.Y., Lin S.J. Magnolol, a potent antioxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits. Basic Res Cardiol 2001, 96:353-363.
49. Ou H.C., Chou F.P., Sheu W.H., Hsu S.L., Lee W.J. Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells. Arch Toxicol 2007, 81:421-432.
50. Lin C.P., Chen Y.H., Leu H.B., Lin S.J., Chen Y.L., Huang S.L., et al. Anti-inflammatory strategies for homocysteine-related cardiovascular disease. Front Biosci 2009, 14:3836-3845.
51. Chen Y.H., Lin S.J., Chen J.W., Ku H.H., Chen Y.L. Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol 2002, 135:37-47.
52. Liou J.Y., Chen Y.L., Loh S.H., Chen P.Y., Hong C.Y., Chen J.J., et al. Magnolol depresses urotensin-II-induced cell proliferation in rat cardiac fibroblasts. Clin Exp Pharmacol Physiol 2009, 36:711-716.
53. Lee M.M., Hseih M.T., Kuo J.S., Yeh F.T., Huang H.M. Magnolol protects cortical neuronal cells from chemical hypoxia in rats. Neuroreport 1998, 9:3451-3456.
54. Lee M.M., Huang H.M., Hsieh M.T., Chen C.S., Yeh F.T., Kuo J.S. Anti-inflammatory and neuroprotective effects of magnolol in chemical hypoxia in rat cultured cortical cells in hypoglycemic media. Chin J Physiol 2000, 43:61-67.
55. Lin Y.R., Chen H.H., Ko C.H., Chan M.H. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 2006, 537:64-69.
56. Ai J., Wang X., Nielsen M. Honokiol and magnolol selectively interact with GABAA receptor subtypes in vitro. Pharmacology 2001, 63:34-41.
57. Watanabe K., Watanabe H.Y., Goto Y., Yamamoto N., Yoshizaki M. Studies on the active principles of magnolia bark. Centrally acting muscle relaxant activity of magnolol and honokiol. Jpn J Pharmacol 1975, 25:605-607.
58. Watanabe K., Watanabe H., Goto Y., Yamaguchi M., Yamamoto N., Hagino K. Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects. Planta Med 1983, 49:103-108.
59. Tsai T.H., Lee T.F., Chen C.F., Wang L.C. Modulatory effects of magnolol on potassium-stimulated 5-hydroxytryptamine release from rat cortical and hippocampal slices. Neurosci Lett 1995, 186:49-52.
60. Nakazawa T., Yasuda T., Ohsawa K. Metabolites of orally administered Magnolia officinalis extract in rats and man and its antidepressant-like effects in mice. J Pharm Pharmacol 2003, 55:1583-1591.
61. Xu Q., Yi L.T., Pan Y., Wang X., Li Y.C., Li J.M., et al. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:715-725.
62. 2+ mobilization in rat uterus. Naunyn Schmiedebergs Arch Pharmacol 2003, 368:262-269.
63. Zhang W.W., Li Y., Wang X.Q., Tian F., Cao H., Wang M.W., et al. Effects of magnolol and honokiol derived from traditional Chinese herbal remedies on gastrointestinal movement. World J Gastroenterol 2005, 11:4414-4418.
64. Bian Z.X., Zhang G.S., Wong K.L., Hu X.G., Liu L., Yang Z., et al. Inhibitory effects of magnolol on distal colon of guinea pig in vitro. Biol Pharm Bull 2006, 29:790-795.
65. Chan S.S., Zhao M., Lao L., Fong H.H., Che C.T. Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum. Planta Med 2008, 74:381-384.
66. Yang T.C., Zhang S.W., Sun L.N., Wang H., Ren A.M. Magnolol attenuates sepsis-induced gastrointestinal dysmotility in rats by modulating inflammatory mediators. World J Gastroenterol 2008, 14:7353-7360.
67. Chen Y.H., Lin F.Y., Liu P.L., Huang Y.T., Chiu J.H., Chang Y.C., et al. Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats. Arch Pharm Res 2009, 32:221-228.
68. Park E.J., Zhao Y.Z., Na M., Bae K., Kim Y.H., Lee B.H., et al. Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide- or d-galactosamine-induced toxicity in rat primary hepatocytes. Planta Med 2003, 69:33-37.
69. Jawan B., Goto S., Pan T.L., Lai C.Y., Luk H.N., Eng H.L., et al. The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver. J Surg Res 2003, 110:378-382.
70. Yin H.Q., Je Y.T., Kim Y.C., Shin Y.K., Sung S., Lee K., et al. Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c. J Pharmacol Sci 2009, 109:486-495.
71. Sohn E.J., Kim C.S., Kim Y.S., Jung D.H., Jang D.S., Lee Y.M., et al. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Life Sci 2007, 80:468-475.
72. Choi S.S., Cha B.Y., Lee Y.S., Yonezawa T., Teruya T., Nagai K., et al. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Life Sci 2009, 84:908-914.
73. Hsieh M.T., Chueh F.Y., Lin M.T. Magnolol decreases body temperature by reducing 5-hydroxytryptamine release in the rat hypothalamus. Clin Exp Pharmacol Physiol 1998, 25:813-817.
74. Tachikawa E., Takahashi M., Kashimoto T. Effects of extract and ingredients isolated from Magnolia obovata thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem Pharmacol 2000, 60:433-440.
75. Chen Y.C., Chang M.F., Chen Y., Wang S.M. Signaling pathways of magnolol-induced adrenal steroidogensis. FEBS Lett 2005, 579:4337-4343.
76. Lin Y.R., Chen H.H., Ko C.H., Chan M.H. Effects of honokiol and magnolol on acute and inflammatory pain models in mice. Life Sci 2007, 81:1071-1078.
77. Lin Y.R., Chen H.H., Lin Y.C., Ko C.H., Chan M.H. Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain. J Biomed Sci 2009, 16:94.
78. Bang K.H., Kim Y.K., Min B.S., Na M.K., Rhee Y.H., Lee J.P., et al. Antifungal activity of magnolol and honokiol. Arch Pharm Res 2000, 23:46-49.
79. Clark A.M., El-Feraly F.S., Li W.S. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci 1981, 70:951-952.
80. Bae E.A., Han M.J., Kim N.J., Kim D.H. Anti-Helicobacter pylori activity of herbal medicines. Biol Pharm Bull 1998, 21:990-992.
81. Lee J., Jung E., Park J., Jung K., Lee S., Hong S., et al. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med 2005, 71:338-343.
82. Wahlstrom B., Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978, 43:86-92.
83. Chen L.C., Liu Y.C., Liang Y.C., Ho Y.S., Lee W.S. Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1. J Agric Food Chem 2009, 57:7331-7337.
84. Matsui N., Takahashi K., Takeichi M., Kuroshita T., Noguchi K., Yamazaki K., et al. Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res 2009, 1305:108-117.